Chemoinformaics analysis of 3,7-di-O-methylQuercetin
| Molecular Weight | 330.292 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 18 |
| Exact Molecular Weight | 330.074 | nRing | 3 |
| Solubility: LogS | -3.716 | nHRing | 1 |
| Solubility: LogP | 3.028 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 43.3391 |
| nHD | 3 | BPOL | 20.1209 |
| QED | 0.633 |
| Synth | 2.414 |
| Natural Product Likeliness | 1.341 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.667 |
| Pgp-sub | 0.004 |
| HIA | 0.022 |
| CACO-2 | -4.942 |
| MDCK | 0.0000124 |
| BBB | 0.007 |
| PPB | 0.936254 |
| VDSS | 0.689 |
| FU | 0.102676 |
| CYP1A2-inh | 0.957 |
| CYP1A2-sub | 0.918 |
| CYP2c19-inh | 0.234 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.663 |
| CYP2c9-sub | 0.889 |
| CYP2d6-inh | 0.533 |
| CYP2d6-sub | 0.742 |
| CYP3a4-inh | 0.381 |
| CYP3a4-sub | 0.135 |
| CL | 7.292 |
| T12 | 0.888 |
| hERG | 0.027 |
| Ames | 0.675 |
| ROA | 0.113 |
| SkinSen | 0.746 |
| Carcinogencity | 0.05 |
| EI | 0.925 |
| Respiratory | 0.175 |
| NR-Aromatase | 0.879 |
| Antiviral | Yes |
| Prediction | 0.859939 |